Medicine
from24/7 Wall St.
4 days agoTop Dividend Stocks Poised for Explosive Growth in 2026 (ABBV, GD, RGR)
AbbVie shows strong stock performance near analyst targets, offers a 2.79% dividend yield, and markets a novel C‑MET–targeting oncology drug, Emrelis.